Health & Fitness

VJHemOnc Podcast

by VJHemOnc

MedicineHealth & Fitness

Is this your show? Claim it

Listen on Apple Podcasts RSS feed

Recently ranked · United States

Last recorded placements from this show’s chart history. These are not current rankings.

Not on the United States charts we track today.

If you like VJHemOnc Podcast, try…

The Myeloma Minutes

Latest episodes

iwMPN 2026 highlights: combination strategies in frontline myelofibrosis and novel agents in the second-line setting

October 30, 2026 · 31 min

This podcast episode features two expert-led roundtable discussions from the recent 4th International Workshop on Myelodysplastic Syndromes and Myeloproliferative Neoplasms (iwMDS/iwMPN 2026) and focuses on updates in myelofibrosis from…
Future perspectives in frontline MCL treatment and management: a European and US view

October 21, 2026 · 17 min

This VJHemOnc podcast episode explores future directions in frontline mantle cell lymphoma (MCL) treatment, focusing on the evolving role of chemotherapy, BTK inhibitors, and autologous stem cell transplantation. Mats Jerkeman, MD, PhD…
Novel targets, combinations, and treatments in AML: highlights from iwAL 2026

October 16, 2026 · 21 min

This episode of the VJHemOnc podcast features an exclusive expert-led roundtable discussion summarizing two sessions from the 8th International Workshop on Acute Leukemias (iwAL 2026) that focused on novel targets, combinations, and…
IMS 2026 highlights: advances in multiple myeloma treatment and the path towards cure

October 9, 2026 · 25 min

In this episode of the VJHemOnc podcast, experts discuss key advances in multiple myeloma presented at the 23rd Annual Meeting and Exposition of the International Myeloma Society (IMS 2026) in Glasgow, UK. Pieter Sonneveld, MD, PhD…
Personalizing BTK Inhibitor Therapy in CLL: from treatment selection to long-term management

October 2, 2026 · 22 min

This VJHemOnc podcast explores how BTK inhibitor therapy can be personalized for patients with chronic lymphocytic leukemia (CLL), considering disease biology, patient characteristics and treatment goals. Kerry Rogers, MD, The Ohio State…

Show 7 more episodesShow fewer episodes

Using BTK inhibitors in lymphoma: practical considerations for community physicians

September 11, 2026 · 23 min

This episode of the VJHemOnc podcast, featuring Manali Kamdar, MD, University of Colorado Cancer Center, Denver, CO, focuses on the practical use of BTK inhibitors (BTKis) in non-Hodgkin lymphoma (NHL). Dr Kamdar begins by discussing which…
AAV gene therapy in hemophilia: progress, challenges and what comes next

September 3, 2026 · 24 min

This VJHemOnc podcast explores the evolving role of gene therapy in hemophilia, focusing on the challenges of AAV-based approaches and the development of next-generation strategies. Radek Kaczmarek, PhD, Indiana University School of…
Clinical considerations in MCL management: frailty assessment, the multidisciplinary team & managing the use of BTKis

August 26, 2026 · 18 min

This VJHemOnc podcast explores the evolving management of mantle cell lymphoma (MCL), from assessing patient fitness to sequencing therapy after BTK inhibitor progression. Tycel Phillips, MD, FASCO, City of Hope, Duarte, CA, and Yasmin…
Sequencing therapies in multiple myeloma: navigating an expanding treatment landscape

August 24, 2026 · 24 min

This VJHemOnc podcast explores the evolving treatment landscape in multiple myeloma, focusing on treatment selection and sequencing across the disease course. Fredrik Schjesvold, MD, PhD, Oslo University Hospital, Oslo, Norway, discusses…
The evolving treatment landscape in ALL: the growing role of immunotherapy and reduced reliance on chemotherapy

August 14, 2026 · 24 min

There has been a significant shift in the treatment of acute lymphoblastic leukemia (ALL), driven by the emergence of novel immunotherapies. In this episode, leading experts explore how these advances are changing the treatment landscape…
Precision medicine in MDS: tailoring treatment through molecular profiling

August 7, 2026 · 20 min

This VJHemOnc podcast explores how precision medicine is reshaping the management of myelodysplastic syndromes (MDS). Alex Bataller, MD, PhD, The University of Texas MD Anderson Cancer Center, Houston, TX, discusses whole genome…
The current and future role of BTK inhibitors across non-Hodgkin lymphoma subtypes

July 23, 2026 · 24 min

This episode of the VJHemOnc podcast explores the current and future role of BTK inhibition across several non-Hodgkin lymphoma (NHL) subtypes. First, Charalampia Kyriakou, MD, PhD, University College London Hospitals NHS Trust (UCLH)…

Full episode archive on Apple Podcasts →

About the show

The Video Journal of Hematology and Hematological Oncology (VJHemOnc) podcast covers the latest hematological oncology and hematology news from international experts – from leukemias, lymphomas, MDS and MPNs, to sickle cell, aplastic anemia and rare diseases. Made for healthcare professionals and researchers, we are a global, independent, open-access platform. Listen to the latest news, including cutting-edge trial updates, controversies and opinion. If you enjoy the podcast, please leave us a rating and review! For more news visit www.vjhemonc.com